Showing 1 posts of 1 posts found.
Alnylam Pharmaceuticals’ shares lost close to half of their value as it was forced to end a trial of its …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant